Skip to main content
. 2015 Feb 2;6(5):597–604. doi: 10.1111/1759-7714.12228

Figure 2.

Figure 2

Overall survival (OS) and disease-free survival (DFS) rates of the stage IIa, IIb, and III patients. (a) The five-year OS rates were 65.6%, 42.7%, and 38.0%, respectively, (P < 0.01). (b) The one, three, and five-year DFS rates were 82.1%, 55.5%, and 49.3%, respectively (P < 0.01). Inline graphic, IIa stage; Inline graphic, IIb stage; Inline graphic, III stage.